Free tool
FAERS Monitor: Synthroid
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021402 or its brand name (Synthroid, Levothyroxine Sodium). Reports on generic versions are filed under their own applications.
Reports
284,278
Serious
170,196
60% of reports
Hospitalization
82,377
Death reported
18,736
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue24,085
- nausea20,602
- drug ineffective19,511
- headache17,631
- diarrhoea17,282
- dyspnoea15,417
- pain15,291
- dizziness14,190
- off label use12,846
- arthralgia12,369
- asthenia12,079
- malaise11,260
- fall10,987
- vomiting10,971
- weight decreased9,152
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 5,676 |
| 2005 | 6,024 |
| 2006 | 6,271 |
| 2007 | 6,361 |
| 2008 | 8,196 |
| 2009 | 8,927 |
| 2010 | 11,698 |
| 2011 | 12,714 |
| 2012 | 15,040 |
| 2013 | 9,851 |
| 2014 | 11,106 |
| 2015 | 16,316 |
| 2016 | 16,838 |
| 2017 | 15,459 |
| 2018 | 15,047 |
| 2019 | 14,927 |
| 2020 | 17,224 |
| 2021 | 15,401 |
| 2022 | 16,286 |
| 2023 | 14,427 |
| 2024 | 14,155 |
| 2025 | 14,954 |
| 2026 | 11,372 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,769,881 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| fallSignal | 10,987 | 2.5 | 2.4 | 9,639 |
| weight decreasedSignal | 9,152 | 2.5 | 2.4 | 7,876 |
| astheniaSignal | 12,079 | 2.4 | 2.4 | 9,942 |
| fatigueSignal | 24,085 | 2.3 | 2.3 | 18,398 |
| arthralgiaSignal | 12,369 | 2.2 | 2.2 | 8,381 |
| dizzinessSignal | 14,190 | 2.1 | 2.1 | 8,544 |
| headacheSignal | 17,631 | 2.1 | 2.1 | 10,338 |
| dyspnoeaSignal | 15,417 | 2.0 | 2.0 | 8,210 |
| diarrhoeaSignal | 17,282 | 2.0 | 2.0 | 8,777 |
| nausea | 20,602 | 2.0 | 1.9 | 9,659 |
| malaise | 11,260 | 1.9 | 1.9 | 4,965 |
| pain | 15,291 | 1.9 | 1.8 | 6,142 |
| vomiting | 10,971 | 1.7 | 1.7 | 3,476 |
| drug ineffective | 19,511 | 1.1 | 1.1 | 175 |
| off label use | 12,846 | 1.1 | 1.1 | 91 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.